Atara Biotherapeutics, Inc.

Connor, Clark & Lunn Investment Management Ltd. ATRA

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/10/2022

Shares

39,307

Value ($000)

149

Weight

0.0%

2020 Q1 - 2022 Q3 (6 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/10/2022	149	0.0%	39,307	9/30/2022
2022 Q2	8/5/2022	817	0.0%	104,898	6/30/2022
2022 Q1	5/12/2022	426	0.0%	45,847	3/31/2022
2021 Q4	2/10/2022	291	0.0%	18,477	12/31/2021
2021 Q3	11/12/2021	286	0.0%	15,964	9/30/2021
2020 Q1	5/13/2020	111	0.0%	13,017	3/31/2020